HAS:NASDAQHasbro, Inc. Analysis
Data as of 2026-08-01 - not real-time
$93.94
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hasbro is trading at $93.94, roughly 16% below the DCF‑derived fair value of $112.74, giving the stock a clear intrinsic upside. Technical indicators are supportive: the price sits well above the 20‑day and 50‑day SMAs, the MACD is bullish, and the RSI at 66.9 suggests momentum without being overbought. Revenue grew 16.2% year‑over‑year to $4.97 B, and margins remain robust with a 63.8% gross margin and a 22.2% operating margin. Cash flow is healthy, delivering $1.29 B in EBITDA and $721 M of free cash flow, while the dividend yield of 2.98% is backed by a 49.8% payout ratio. The balance sheet shows high leverage (debt‑to‑equity ~484), but the company holds $1.38 B in cash, mitigating immediate liquidity concerns. Analyst consensus is a strong‑buy with a median target of $110.5, reinforcing the upside narrative.
The valuation appears undervalued relative to intrinsic models, though price‑to‑book is elevated, indicating a blend of growth and value characteristics. Volatility is elevated at 38% over 30 days, yet beta below 1 points to lower systematic risk, and the consumer‑cyclical sector adds a modest cyclical exposure. The dividend is deemed sustainable, and the brand portfolio (e.g., Monopoly, Transformers, Nerf) provides a durable competitive moat. Overall, the risk profile is moderate, supporting a buy recommendation for medium‑ to long‑term horizons while a hold stance is prudent in the near term pending post‑earnings confirmation.
The valuation appears undervalued relative to intrinsic models, though price‑to‑book is elevated, indicating a blend of growth and value characteristics. Volatility is elevated at 38% over 30 days, yet beta below 1 points to lower systematic risk, and the consumer‑cyclical sector adds a modest cyclical exposure. The dividend is deemed sustainable, and the brand portfolio (e.g., Monopoly, Transformers, Nerf) provides a durable competitive moat. Overall, the risk profile is moderate, supporting a buy recommendation for medium‑ to long‑term horizons while a hold stance is prudent in the near term pending post‑earnings confirmation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages and bullish MACD
- Recent earnings release may cause near‑term volatility
- Increasing volume supporting current trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 16% intrinsic upside to DCF fair value
- Strong revenue growth and high operating margins
- Sustainable dividend and solid free cash flow
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust brand portfolio with licensing revenue streams
- Consistent dividend yield with comfortable payout ratio
- Long‑term growth potential in digital and entertainment extensions
Key Metrics & Analysis
Financial Health
Revenue Growth16.20%
Profit Margin15.97%
P/E Ratio16.7
ROE159.56%
ROA13.02%
Debt/Equity484.49
P/B Ratio20.5
Op. Cash Flow$1.3B
Free Cash Flow$721.9M
Technical Analysis
TrendNeutral
RSI66.9
Support$75.19
Resistance$97.00
MA 20$84.76
MA 50$84.75
MA 200$87.41
MACDBullish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$112.74
Target Price$109.07
Upside/Downside16.11%
GradeUndervalued
TypeBlend
Dividend Yield2.98%
Risk Assessment
Beta0.86
Volatility38.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.